Academic Health Center
Stay Connected
research-and-clinical-trials

Research Snapshot: People of color still drastically underrepresented in NIH clinical trials

New numbers from the Enhancing Minority Participation in Clinical Trials (EMPaCT) consortium show less than five percent of National Institutes of Health (NIH) clinical trial participants are non-white and less than two percent of clinical cancer research trials focus on non-white ethnic or racial groups.

Author and principal investigator Jasjit Ahluwalia, M.D., M.P.H., a professor of medicine in the University of Minnesota of Medical School, expressed his displeasure with the results.

“These new findings highlight the continued disparities in the enrollment of ethnic minorities into clinical trials,” said Ahluwalia.  “Scientists, patients and communities must work together to ensure a reversal, to achieve our goal of health equity.”

Read more
news-and-notes

U of M Medical Center recognized in national kidney transplant chain

The University of Minnesota Medical Center was recently recognized for its participation in the National Kidney Registry’s 1000th paired exchange transplant.

The Medical Center was part of a chain of ten transplants, which occurred at prominent treatment centers across the country.

Transplants first began over six years ago in February of 2008. Now, at over 1,000 successful procedures, many people have begun to live healthier lives…

Read more
research-and-clinical-trials

U of M study: Walking while working improves health, may boost productivity

According to new research from the University of Minnesota Carlson School of Management, walking on a treadmill during the workday not only improves health, it can also potentially boost productivity.

Researchers outfitted 40 workstations at a Twin Cities financial services company with a computer, phone, writing area and treadmill. As subjects worked, they could adjust their walking speed up to two mph. To help gauge workout intensity, each subject was also given an energy expenditure device to be worn during work hours…

Read more
research-and-clinical-trials

Research Snapshot: Treatment and survival trends in patients with early laryngeal cancer

Stephanie Misono, M.D. M.P.H., and colleagues within the University of Minnesota School of Public Health and School of Medicine recently released the results of a study examining trends in treatment of people within the early stages of laryngeal cancer.

The objectives of this study were

  • To identify factors associated with treatment differences.
  • Characterize changes in treatment patterns over time.
  • Compare survival rates across treatment types in patients who received treatment.

Using a cancer surveillance database, researchers analyzed rates and trends in patients who were treated from 1995 to 2009. 10,429 adult patients diagnosed with early cancer of the larynx (voicebox) were studied…

Read more
in-the-news

In the News: U of M offers new cancer treatment for neuroblastoma

Neuroblastoma, a type of childhood cancer, is difficult to treat. And according to the American Cancer Institute, about 700 people in the United States are diagnosed with this form of cancer each year.

Raymond Yeager has dealt with the neuroblastoma since he was 14 years old. Now 20, he’s undergone many treatments including chemotherapy, radiation therapy, surgery, a stem cell transplant and immunotherapy. Unfortunately, nothing has helped…

Read more
in-the-news

In the News: U of M doctor offers expertise on rare condition

Teenagers Jonathon and Christopher Naquin of Humble, Texas have never been able to pinpoint the cause of their mysterious symptoms.

Since childhood, Jonathon, 18, and Christopher, 16, experienced significant levels of protein and blood in their urine and even suffered hearing loss while in elementary school.

But now, after years of tests and baffling doctors, the two boys and their family finally received the answer they were looking for: Alport Syndrome. Never heard of it? You’re not alone…

Read more